Comparing the cost-effectiveness of HIV prevention interventions

被引:84
作者
Cohen, DA
Wu, SY
Farley, TA
机构
[1] RAND Corp, Santa Monica, CA 90405 USA
[2] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA
关键词
HIV prevention; cost-effectiveness; policy; community planning; economics;
D O I
10.1097/01.qai.0000123271.76723.96
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Communities need to identify cost-effective interventions for HIV prevention to optimize limited resources. Methods: The authors developed a spreadsheet tool using Bernoulli and proportionate change models to estimate the relative cost-effectiveness for 26 HIV prevention interventions including biomedical interventions, structural interventions, and interventions designed to change risk behaviors of individuals. They also conducted sensitivity analyses to assess patterns of the cost-effectiveness across different populations using various assumptions. Results: The 2 factors most strongly determining the cost-effectiveness of the different interventions were the HIV prevalence of the population at risk and the cost per person reached. In low-prevalence populations (eg, heterosexuals) the most cost-effective interventions were structural interventions (eg, mass media, condom distribution), whereas in high-prevalence populations (eg, men who have sex with men) individually focused interventions to change risk behavior were also relatively cost-effective. Among the most cost-effective interventions overall were showing videos in STD clinics and raising alcohol taxes. School-based HIV prevention programs appeared to be the least cost-effective. Needle exchange and needle deregulation programs were relatively cost-effective only when injection drug users have a high HIV prevalence. Conclusions: Comparing estimates of the cost-effectiveness of HIV interventions provides insight that can help local communities maximize the impact of their HIV prevention resources.
引用
收藏
页码:1404 / 1414
页数:11
相关论文
共 54 条
  • [1] ALLARD R, 1990, J ACQ IMMUN DEF SYND, V3, P1010
  • [2] Condom distribution: a cost-utility analysis
    Bedimo, AL
    Pinkerton, SD
    Cohen, DA
    Gray, B
    Farley, TA
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (06) : 384 - 392
  • [3] CHEESON CW, 2000, J ACQ IMMUN DEF SYND, V24, P48
  • [4] Implementation of condom social marketing in Louisiana, 1993 to 1996
    Cohen, DA
    Farley, TA
    Bedimo-Etame, JR
    Scribner, R
    Ward, W
    Kendall, C
    Rice, J
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (02) : 204 - 208
  • [5] An STD/HIV prevention intervention framework
    Cohen, DA
    Scribner, R
    [J]. AIDS PATIENT CARE AND STDS, 2000, 14 (01) : 37 - 45
  • [6] Short-term impact of safer choices: A multicomponent, school-based HIV, other STD, and pregnancy prevention program
    Coyle, K
    Basen-Engquist, K
    Kirby, D
    Parcel, G
    Banspach, S
    Harrist, R
    Baumler, E
    Weil, M
    [J]. JOURNAL OF SCHOOL HEALTH, 1999, 69 (05) : 181 - 188
  • [7] Increased condom use without other major changes in sexual behavior among the general population in Switzerland
    DuboisArber, F
    Jeannin, A
    Konings, E
    Paccaud, F
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (04) : 558 - 566
  • [8] FARLEY T, 2003, IN PRESS JAIDS
  • [9] GROSECLOSE SL, 1995, J ACQ IMMUN DEF SYND, V10, P82
  • [10] IMPACT OF IMPROVED TREATMENT OF SEXUALLY-TRANSMITTED DISEASES ON HIV-INFECTION IN RURAL TANZANIA - RANDOMIZED CONTROLLED TRIAL
    GROSSKURTH, H
    MOSHA, F
    TODD, J
    MWIJARUBI, E
    KLOKKE, A
    SENKORO, K
    MAYAUD, P
    CHANGALUCHA, J
    NICOLL, A
    KAGINA, G
    NEWELL, J
    MUGEYE, K
    MABEY, D
    HAYES, R
    [J]. LANCET, 1995, 346 (8974): : 530 - 536